CD68, CD163, and matrix metalloproteinase 9 (MMP-9) in breast tumor microenvironment to predict breast cancer survival: are they enough?

Por Bravaccini, Sara, Maltoni, Roberta
Publicado no Breast Cancer Res (2019)

Clinical utility of fulvestrant in the treatment of breast cancer: a report on the emerging clinical evidence

Por Rocca, Andrea, Maltoni, Roberta, Bravaccini, Sara, Donati, Caterina, Andreis, Daniele
Publicado no Cancer Manag Res (2018)

Spotlight on Ki67 as a prognostic marker in early breast cancer: all that glitters may not be gold

Por Maltoni, Roberta, Palleschi, Michela, Ravaioli, Sara, Tumedei, Maria Maddalena, Altini, Mattia, Bravaccini, Sara
Publicado no Diagn Pathol (2020)

Progress with palbociclib in breast cancer: latest evidence and clinical considerations

Por Rocca, Andrea, Schirone, Alessio, Maltoni, Roberta, Bravaccini, Sara, Cecconetto, Lorenzo, Farolfi, Alberto, Bronte, Giuseppe, Andreis, Daniele
Publicado no Ther Adv Med Oncol (2016)

Impressive long-term response with chemo-endocrine therapy in a premenopausal patient with metastatic breast cancer: A case report

Por Maltoni, Roberta, Palleschi, Michela, Gallerani, Giulia, Bravaccini, Sara, Cecconetto, Lorenzo, Melegari, Elisabetta, Altini, Mattia, Rocca, Andrea
Publicado no Medicine (Baltimore) (2020)

Androgen and oestrogen receptors as potential prognostic markers for patients with ductal carcinoma in situ treated with surgery and radiotherapy

Por Ravaioli, Sara, Tumedei, Maria Maddalena, Foca, Flavia, Maltoni, Roberta, Rocca, Andrea, Massa, Ilaria, Pietri, Elisabetta, Bravaccini, Sara
Publicado no Int J Exp Pathol (2017)

Can cyclin-dependent kinase 4/6 inhibitors convert inoperable breast cancer relapse to operability? A case report

Por Palleschi, Michela, Maltoni, Roberta, Barzotti, Eleonora, Melegari, Elisabetta, Curcio, Annalisa, Cecconetto, Lorenzo, Sarti, Samanta, Manunta, Silvia, Rocca, Andrea
Publicado no World J Clin Cases (2020)

Phase II study of gemcitabine, doxorubicin and paclitaxel (GAT) as first-line chemotherapy for metastatic breast cancer: a translational research experience

Por Maltoni Roberta, Nanni Oriana, Zumaglini Federica, Milandri Carlo, Gianni Lorenzo, Zoli Wainer, Massa Ilaria, Passardi Alessandro, Frassineti Giovanni, Amadori Dino
Publicado em 2006-03-01

Evaluation of Androgen Receptor in Relation to Estrogen Receptor (AR/ER) and Progesterone Receptor (AR/PgR): A New Must in Breast Cancer?

Por Bronte, Giuseppe, Rocca, Andrea, Ravaioli, Sara, Scarpi, Emanuela, Bonafè, Massimiliano, Puccetti, Maurizio, Maltoni, Roberta, Andreis, Daniele, Martinelli, Giovanni, Bravaccini, Sara
Publicado no J Oncol (2019)

Phase II study of gemcitabine, doxorubicin and paclitaxel (GAT) as first-line chemotherapy for metastatic breast cancer: a translational research experience

Por Passardi, Alessandro, Massa, Ilaria, Zoli, Wainer, Gianni, Lorenzo, Milandri, Carlo, Zumaglini, Federica, Nanni, Oriana, Maltoni, Roberta, Frassineti, Giovanni Luca, Amadori, Dino
Publicado em 2006

Single shot ultrasound-guided thoracic paravertebral block for opioid-free radical mastectomy: a prospective observational study

Por Santonastaso, Domenico P, de Chiara, Annabella, Russo, Emanuele, Musetti, Giovanni, Lucchi, Leonardo, Sibilio, Andrea, Maltoni, Roberta, Gamberini, Emiliano, Fusari, Maurizio, Agnoletti, Vanni
Publicado no J Pain Res (2019)

Addition of 5-fluorouracil to doxorubicin-paclitaxel sequence increases caspase-dependent apoptosis in breast cancer cell lines

Por Zoli, Wainer, Ulivi, Paola, Tesei, Anna, Fabbri, Francesco, Rosetti, Marco, Maltoni, Roberta, Giunchi, Donata Casadei, Ricotti, Luca, Brigliadori, Giovanni, Vannini, Ivan, Amadori, Dino
Publicado em 2005

Cell-free DNA detected by “liquid biopsy” as a potential prognostic biomarker in early breast cancer

Por Maltoni, Roberta, Casadio, Valentina, Ravaioli, Sara, Foca, Flavia, Tumedei, Maria Maddalena, Salvi, Samanta, Martignano, Filippo, Calistri, Daniele, Rocca, Andrea, Schirone, Alessio, Amadori, Dino, Bravaccini, Sara
Publicado no Oncotarget (2017)

RANK/RANK-L/OPG in Patients with Bone Metastases Treated with Anticancer Agents and Zoledronic Acid: A Prospective Study

Por Mercatali, Laura, Ricci, Marianna, Scarpi, Emanuela, Serra, Patrizia, Fabbri, Francesca, Ricci, Rossana, Liverani, Chiara, Zanoni, Michele, Zoli, Wainer, Maltoni, Roberta, Gunelli, Erica, Amadori, Dino, Ibrahim, Toni
Publicado em 2013

Phase Ib dose-finding trial of lapatinib plus pegylated liposomal doxorubicin in advanced HER2-positive breast cancer

Por Rocca, Andrea, Cecconetto, Lorenzo, Passardi, Alessandro, Melegari, Elisabetta, Andreis, Daniele, Monti, Manuela, Maltoni, Roberta, Sarti, Samanta, Pietri, Elisabetta, Schirone, Alessio, Fabbri, Francesco, Donati, Caterina, Nanni, Oriana, Fedeli, Anna, Faedi, Marina, Amadori, Dino
Publicado no Cancer Chemother Pharmacol (2017)

Androgen Receptor Expression in Breast Cancer: What Differences Between Primary Tumor and Metastases?

Por Bronte, Giuseppe, Bravaccini, Sara, Ravaioli, Sara, Puccetti, Maurizio, Scarpi, Emanuela, Andreis, Daniele, Tumedei, Maria Maddalena, Sarti, Samanta, Cecconetto, Lorenzo, Pietri, Elisabetta, De Simone, Valeria, Maltoni, Roberta, Bonafè, Massimiliano, Amadori, Dino, Rocca, Andrea
Publicado no Transl Oncol (2018)

Are There Differences in Androgen Receptor Expression in Invasive Breast Cancer in African (Tanzanian) Population in Comparison With the Caucasian (Italian) Population?

Por Bravaccini, Sara, Ravaioli, Sara, Amadori, Dino, Scarpi, Emanuela, Puccetti, Maurizio, Rocca, Andrea, Tumedei, Maria Maddalena, Masalu, Nestory, Kahima, Jackson, Pangan, Akwilina, Faustine, Lucas, Farolfi, Alberto, Maltoni, Roberta, Bonafè, Massimiliano, Serra, Patrizia, Bronte, Giuseppe
Publicado no Front Endocrinol (Lausanne) (2018)

Androgen receptor in advanced breast cancer: is it useful to predict the efficacy of anti-estrogen therapy?

Por Bronte, Giuseppe, Rocca, Andrea, Ravaioli, Sara, Puccetti, Maurizio, Tumedei, Maria Maddalena, Scarpi, Emanuela, Andreis, Daniele, Maltoni, Roberta, Sarti, Samanta, Cecconetto, Lorenzo, Fedeli, Anna, Pietri, Elisabetta, De Simone, Valeria, Asioli, Silvia, Amadori, Dino, Bravaccini, Sara
Publicado no BMC Cancer (2018)

The impact of progesterone receptor expression on prognosis of patients with rapidly proliferating, hormone receptor-positive early breast cancer: a post hoc analysis of the IBIS 3...

Por Bravaccini, Sara, Bronte, Giuseppe, Scarpi, Emanuela, Ravaioli, Sara, Maltoni, Roberta, Mangia, Anita, Tumedei, Maria Maddalena, Puccetti, Maurizio, Serra, Patrizia, Gianni, Lorenzo, Amaducci, Laura, Biglia, Nicoletta, Bounous, Valentina, Paradiso, Angelo Virgilio, Silvestrini, Rosella, Amadori, Dino, Rocca, Andrea
Publicado no Ther Adv Med Oncol (2020)

Ki67 and PR in Patients Treated with CDK4/6 Inhibitors: A Real-World Experience

Por Palleschi, Michela, Maltoni, Roberta, Ravaioli, Sara, Vagheggini, Alessandro, Mannozzi, Francesca, Fanini, Francesca, Pirini, Francesca, Tumedei, Maria Maddalena, Barzotti, Eleonora, Cecconetto, Lorenzo, Sarti, Samanta, Manunta, Silvia, Possanzini, Paola, Fedeli, Anna, Curcio, Annalisa, Altini, Mattia, De Giorgi, Ugo, Rocca, Andrea, Bravaccini, Sara
Publicado no Diagnostics (Basel) (2020)